阿奇霉素治疗感染性疾病的临床疗效评价

发布时间：2018-04-27 01:37

本文选题：革兰阴性球菌 + 临床疗效评价　；参考：《中国医院用药评价与分析》2016年02期

【摘要】：正近年来,大环内酯类抗菌药物开发出一些新品种,其抗菌活性强,组织、细胞内浓度高且半衰期长,并具有良好的抗菌药物后效应,对临床常见的革兰阳性球菌、革兰阴性球菌、部分革兰阴性杆菌有较好的效果,对非典型致病菌(军团菌、肺炎支原体、衣原体)等亦具有良好的疗效,已成为临床上治疗感染性疾病不可或缺的药物。阿奇霉素属于大环内酯类抗菌药物,在临床上应用十分广泛,为指导临床安全、有效、经济地使用阿奇霉素,本文查阅了近年来国内有关阿奇霉素合理使用相关文
[Abstract]:In recent years, some new antimicrobial agents of macrolides have been developed. They have strong antibacterial activity, high tissue, high intracellular concentration and long half-life, and have good post-antimicrobial effect on gram-positive cocci. Gram-negative cocci and some gram-negative bacilli have a good effect on atypical pathogenic bacteria (Legionella pneumoniae chlamydia) and have become an indispensable drug in the treatment of infectious diseases. Azithromycin belongs to macrolide antibiotics and is widely used in clinic. In order to guide the safe, effective and economical use of azithromycin in clinic, this article has consulted the relevant articles on the rational use of azithromycin in China in recent years.
【作者单位】：麻城市卫生监督局医疗监督科;麻城市人民医院药学部;
【分类号】：R51

【相似文献】